Skip to search formSkip to main contentSkip to account menu

montelukast 10 MG Oral Tablet

Known as: MONTELUKAST SODIUM 10 mg ORAL TABLET, COATED, montelukast 10 MG (as montelukast sodium 10.4 MG) Oral Tablet, MONTELUKAST NA 10MG TAB,UD 
National Institutes of Health

Related topics

Related topics

41 relations
AsthmaCroscarmellose SodiumDrug AllergyEdetic Acid, Disodium Salt

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Orta-Ağır Akut Astım Atağı ile Başvuran 6-16 Yaş arası Çocuklarda Montelukastın Etkinliğinin Belirlenmesi
Oz: Bu calismanin amaci  orta veya agir siddette astim atagi ile  basvuran 6-16 yaslar arasindaki  hastalardaki solunum… 
2017
2017
Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified
It has recently been shown that the leukotriene receptor antagonist montelukast rejuvenates aged brains in rats. The question is… 
Review
2017
Review
2017
Le syndrome de Widal en pratique clinique
Zusammenfassung. Das Widal-Syndrom umfasst eine klinische Trias mit chroniquer Rhinosinusitis und nasalen Polypen, Asthma… 
2014
2014
Montelukast ilişkili Churg Strauss Sendromu: Üç Olgu
Churg-Strauss Sendromu yeni adiyla Eozinofilik Granulomatosis ve Polianjiitis; astim, ates, periferik kanda eozinofili… 
2013
2013
Positive inotropic activity exerted by the montelukast- androsterone derivative in a model of congestive heart failure (CHF)
Several studies indicate that some steroid derivatives have inotropic activity; nevertheless, there is scarce information about… 
2008
2008
MONTELUKAST COMO ADYUVANTE A LA TERAPIA CORTICOIDAL ORAL E INHALADA EN POLIPOSIS NASAL CRÓNICA
2005
2005
Die Wirkung von Montelukast auf Rhinitissymptome bei Patienten mit Asthma und saisonaler allergischer Rhinitis
Objective: The objective of this study was to evaluate montelukast 10 mg daily as treatment for allergic rhinitis in patients… 
2005
2005
Polymorphes d'acide sans montelukast
La presente invention concerne des formes amorphes et polymorphes d'acide exempt de montelukast. 
2003
2003
Procede de preparation ameliore d'acide montelukast et de sel de sodium de celui-ci sous forme amorphe
La presente invention concerne un procede de preparation d'acide montelukast et de sel de sodium de celui-ci sous forme amorphe… 
1998
1998
THERAPIE DES ASTHMA BRONCHIALE : DER NEUE LEUKOTRIEN-REZEPTORANTAGONIST MONTELUKAST
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)